Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder

NCT05301335 is registered in ClinicalTrials.gov with SpineX Inc. as lead sponsor.

NCT NCT05301335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05301335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder
Lead sponsor
SpineX Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2022
Completion date
May 1, 2024
Enrollment
126 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, neurogenic bladder, spinal cord injuries (complete and incomplete), stroke